» Articles » PMID: 12909725

Targeted Gene Evolution in Escherichia Coli Using a Highly Error-prone DNA Polymerase I

Overview
Specialty Science
Date 2003 Aug 12
PMID 12909725
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

We present a system for random mutagenesis in Escherichia coli for the evolution of targeted genes. To increase error rates of DNA polymerase I (Pol I) replication, we introduced point mutations in three structural domains that govern Pol I fidelity. Expression of error-prone Pol I in vivo results in strong mutagenesis of a target sequence encoded in a Pol I-dependent plasmid (8.1 x 10-4 mutations per bp, an 80,000-fold increase), with a preference for plasmid relative to chromosome sequence. Mutagenesis is maximal in cultures maintained at stationary phase. Mutations are evenly distributed and show a variety of base pair substitutions, predominantly transitions. Mutagenesis extends at least 3 kb beyond the 400-500 nt reportedly synthesized by Pol I. We demonstrate that our error-prone Pol I can be used to generate enzymes with distinct properties by generating TEM-1 beta-lactamase mutants able to hydrolyze a third-generation lactam antibiotic, aztreonam. Three different mutations contribute to aztreonam resistance. Two are found in the extended-spectrum beta-lactamases most frequently identified in clinical isolates, and the third (G276R) has not been previously described. Our system of targeted mutagenesis in E. coli should have an impact on enzyme-based applications in areas such as synthetic chemistry, gene therapy, and molecular biology. Given the structural conservation between polymerases, this work should also provide a reference for altering the fidelity of other polymerases.

Citing Articles

Harnessing microbial heterogeneity for improved biosynthesis fueled by synthetic biology.

Cao Y, Li J, Liu L, Du G, Liu Y Synth Syst Biotechnol. 2024; 10(1):281-293.

PMID: 39686977 PMC: 11646789. DOI: 10.1016/j.synbio.2024.11.004.


Development of a new affinity maturation protocol for the construction of an internalizing anti-nucleolin antibody library.

Ribeiro R, Moreira J, Goncalves J Sci Rep. 2024; 14(1):10608.

PMID: 38719911 PMC: 11079059. DOI: 10.1038/s41598-024-61230-z.


Ultrahigh-throughput screening-assisted in vivo directed evolution for enzyme engineering.

Chen S, Yang Z, Zhong Z, Yu S, Zhou J, Li J Biotechnol Biofuels Bioprod. 2024; 17(1):9.

PMID: 38254175 PMC: 10804518. DOI: 10.1186/s13068-024-02457-w.


Evolution and synthetic biology.

Ornelas M, Cournoyer J, Bram S, Mehta A Curr Opin Microbiol. 2023; 76:102394.

PMID: 37801925 PMC: 10842511. DOI: 10.1016/j.mib.2023.102394.


In vivo hypermutation and continuous evolution.

Molina R, Rix G, Mengiste A, Alvarez B, Seo D, Chen H Nat Rev Methods Primers. 2023; 2.

PMID: 37073402 PMC: 10108624. DOI: 10.1038/s43586-022-00130-w.


References
1.
Negri M, Lipsitch M, Blazquez J, Levin B, Baquero F . Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance. Antimicrob Agents Chemother. 2000; 44(9):2485-91. PMC: 90089. DOI: 10.1128/AAC.44.9.2485-2491.2000. View

2.
Liu A, Schellenberger V . Rapid in vivo evolution of a beta-lactamase using phagemids. Biotechnol Bioeng. 2000; 68(1):121-5. DOI: 10.1002/(sici)1097-0290(20000405)68:1<121::aid-bit15>3.0.co;2-x. View

3.
Fabret C, Poncet S, Danielsen S, Borchert T, Ehrlich S, Janniere L . Efficient gene targeted random mutagenesis in genetically stable Escherichia coli strains. Nucleic Acids Res. 2000; 28(21):E95. PMC: 113164. DOI: 10.1093/nar/28.21.e95. View

4.
Orencia M, Yoon J, Ness J, Stemmer W, Stevens R . Predicting the emergence of antibiotic resistance by directed evolution and structural analysis. Nat Struct Biol. 2001; 8(3):238-42. DOI: 10.1038/84981. View

5.
Patel P, Suzuki M, Adman E, SHINKAI A, Loeb L . Prokaryotic DNA polymerase I: evolution, structure, and "base flipping" mechanism for nucleotide selection. J Mol Biol. 2001; 308(5):823-37. DOI: 10.1006/jmbi.2001.4619. View